| GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia PA Greif, A Dufour, NP Konstandin, B Ksienzyk, E Zellmeier, B Tizazu, ... Blood, The Journal of the American Society of Hematology 120 (2), 395-403, 2012 | 178 | 2012 |
| CentiServer: a comprehensive resource, web-based application and R package for centrality analysis M Jalili, A Salehzadeh-Yazdi, Y Asgari, SS Arab, M Yaghmaie, ... PloS one 10 (11), e0143111, 2015 | 120 | 2015 |
| Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia M YAGHMAEI, SHA GHAFARI, A GHAVAMZADEH, MK ALI, M Jahani, ... ARCHIVES OF IRANIAN MEDICINE 11 (3), 247-251, 2008 | 110 | 2008 |
| Evolution of centrality measurements for the detection of essential proteins in biological networks M Jalili, A Salehzadeh-Yazdi, S Gupta, O Wolkenhauer, M Yaghmaie, ... Frontiers in physiology 7, 375, 2016 | 80 | 2016 |
| Molecular mechanisms of resistance to tyrosine kinase inhibitors M Yaghmaie, CCS Yeung Current Hematologic Malignancy Reports 14, 395-404, 2019 | 46 | 2019 |
| Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma M Ahmadvand, M Eskandari, H Pashaiefar, M Yaghmaie, ... Leukemia research 70, 45-48, 2018 | 45 | 2018 |
| Somatic mutations in acute promyelocytic leukemia (APL) identified by exome sequencing PA Greif, M Yaghmaie, NP Konstandin, B Ksienzyk, K Alimoghaddam, ... Leukemia 25 (9), 1519-1522, 2011 | 38 | 2011 |
| Low expression of long noncoding RNA IRAIN is associated with poor prognosis in non-M3 acute myeloid leukemia patients H Pashaiefar, M Izadifard, M Yaghmaie, M Montazeri, E Gheisari, ... Genetic testing and molecular biomarkers 22 (5), 288-294, 2018 | 36 | 2018 |
| Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells M Momeny, Z Sabourinejad, G Zarrinrad, F Moghaddaskho, H Eyvani, ... Scientific reports 7 (1), 45954, 2017 | 34 | 2017 |
| Prognostic value of RUNX1 mutations in AML: a meta-analysis M Jalili, M Yaghmaie, M Ahmadvand, K Alimoghaddam, SA Mousavi, ... Asian Pacific journal of cancer prevention: APJCP 19 (2), 325, 2018 | 32 | 2018 |
| Expression Analysis of PVT1, CCDC26, and CCAT1 Long Noncoding RNAs in Acute Myeloid Leukemia Patients M Izadifard, H Pashaiefar, M Yaghmaie, M Montazeri, M Sadraie, ... Genetic Testing and Molecular Biomarkers 22 (10), 593-598, 2018 | 30 | 2018 |
| In vitro induction of potent tumor-specific cytotoxic T lymphocytes using TLR agonist-activated AML-DC M Nourizadeh, F Masoumi, A Memarian, K Alimoghaddam, SM Moazzeni, ... Targeted oncology 9, 225-237, 2014 | 29 | 2014 |
| Inhibitor of aurora kinase B induces differentially cell death and polyploidy via DNA damage response pathways in neurological malignancy: shedding new light on the challenge … A Zekri, SH Ghaffari, M Yaghmaie, MA Estiar, K Alimoghaddam, ... Molecular neurobiology 53, 1808-1823, 2016 | 25 | 2016 |
| AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy A Zekri, SH Ghaffari, S Ghanizadeh-Vesali, M Yaghmaie, A Salmaninejad, ... Tumor Biology 36, 623-632, 2015 | 24 | 2015 |
| Altered expression of MALAT1 lncRNA in chronic lymphocytic leukemia patients, correlation with cytogenetic findings A Ahmadi, S Kaviani, M Yaghmaie, H Pashaiefar, M Ahmadvand, M Jalili, ... Blood research 53 (4), 320, 2018 | 23 | 2018 |
| Osteopontin b and c splice isoforms in leukemias and solid tumors: angiogenesis alongside chemoresistance A Mirzaei, S Mohammadi, SH Ghaffari, M Yaghmaie, M Vaezi, ... Asian Pacific Journal of Cancer Prevention: APJCP 19 (3), 615, 2018 | 21 | 2018 |
| PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia H Pashaiefar, M Yaghmaie, J Tavakkoly-Bazzaz, SH Ghaffari, ... Genetic testing and molecular biomarkers 22 (6), 343-349, 2018 | 19 | 2018 |
| Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway M Momeny, R Ghasemi, G Valenti, M Miranda, A Zekri, G Zarrinrad, ... Tumor Biology 37, 3913-3923, 2016 | 18 | 2016 |
| Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: a proteomic study of molecular targets A Nasrollahzadeh, M Momeny, H Fasehee, M Yaghmaie, D Bashash, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1868 (10), 119087, 2021 | 17 | 2021 |
| Methylation analysis of P16, RASSF1A, RPRM, and RUNX3 in circulating cell-free DNA for detection of gastric cancer: a validation study K Saliminejad, SS Fard, HRK Khorshid, M Yaghmaie, H Mahmoodzadeh, ... Avicenna Journal of Medical Biotechnology 12 (2), 99, 2020 | 17 | 2020 |
Seyed H. GhaffariProfessor, Hematology, Oncology & Stem Cell Transplantation Research Center, Shariati Hospital, University of Tehran Medical Science, Tehran, Iran在 tums.ac.ir 的电子邮件经过验证
